Clinical implications of adipose tissue remodelling: Adipogenesis and apoptosis

Canadian Journal of Diabetes

Volumn 26, Issue 3, 2002, Pages 232-240

  Sorisky, Alexander ^a   Gagnon, Annemarie ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845668250     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Ailhaud G, Grimaldi P, Negrel R. Cellular and molecular aspects of adipose tissue development. Annu Rev Nutr. 1992;12:207-233.
2. Pilgrim C. DNA synthesis and differentiation in developing white adipose tissue. Dev Biol. 1971;26:69-76.
3. Cook JR, Kozak LP. Sn-glycerol-3-phosphate dehydrogenase gene expression during mouse adipocvte development in vivo. Dev Biol. 1982;92:440-448.
4. Poznanski WJ, Walieed I, Van R. Human fat cell precursors. Morphologic and metabolic differentiation in culture. Lab Invest. 1973;29:570-576.
5. Hauner H, Entenmann G, Wabitsch M, et al. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest. 1989;84:1663-1670.
6. Adams M, Montague CT, Prins JB, et al. Activators of peroxisome proliferator-activated receptor γ have depot-specific effects on human preadipocvte differentiation. J Clin Invest. 1997;100:3149-3153.
7. Rosen ED, Walkev CJ, Puigserver P, Spiegelman BM. Transcriptional regulation of adipogenesis. Genes Dev. 2000;14:1293-1307.
8. Sugihara H, Funatsumaru S, Yonemitsu N, et al. A simple culture method of fat cells from mature fat tissue fragments. J Lipid Res. 1989;30:1987-1995.
9. Green H, Kehinde O. Sublines of mouse 3T3 cells diat accumulate lipid. Cell. 1974;1:113-116.
10. Novikoff AB, Novikoff PM, Rosen OM, Rubin CS. Organelle relationships in cultured 3T3-L1 preadipocytes. J Cell Biol. 1980;87:180-196.
11. Mandrup S, Loftus TM, MacDougald OA, et al. Obese gene expression at in vivo levels bv fat pads derived from s.c. implanted 3T3-F442A preadipocytes. Proc Natl Acad Sci USA. 1997;94:4300-4305.
12. Accili D, Tavlor SI. Targeted inactivation of the insulin receptor gene in mouse 3T3-L1 fibroblasts via homologous recombination. Proc Natl Acad Sci USA. 1991;88:4708-4712.
13. Entenmann G, Hauner H. Relationship between replication and differentiation in cultured human adipocvte precursor cells. Am J Physiol. 1996;270:C1011-C1016.
14. Soukas A, Socci ND, Saatkamp BD, et al. Distinct transcriptional profiles of adipogenesis in vivo and in vitro. J Biol Chem. 2001;276:34167-34174.
15. Soriskv A. From preadipocvte to adipocyte: differentiation-directed signals of insulin from the cell surface to die nucleus. Grit Rev Clin Lab Sci. 1999;36:1-34.
16. Rubin CS, Hirsch A, Fung C, Rosen OM. Development of hormone receptors and hormonal responsiveness in vitro. Insulin receptors and insulin sensitivity in the preadipocyte and adipocvte forms of 3T3-L1 cells. J Biol Chem. 1978;253:7570-7578.
17. Morrison RF, Farmer SR. Hormonal signaling and transcriptional control of adipocyte differentiation. J Nutr. 2000;130:3116S-3121S.
18. Hirsch J, Fried SK, Edens NK, Leibel RL. The fat cell. Med Clin North Am. 1989;73:83-96.
19. Danforth E Jr. Failure of adipocvte differentiation causes tvpe II diabetes mellitus [letter]? Nat Genet. 2000;26:13.
20. Yamauchi T, Kamon J, Waki H, et al. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor γ (PPARγ) deficiency and PPARγ agonist improve insulin resistance. J Biol Chem. 2001;276:41245-41254.
21. Hotamisligil GS, Arner P, Caro JF, et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995;95:2409-2415.
22. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941-946.
23. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest. 2000;106:171-176.
24. Linger RH, Zhou Y-T Lipotoxicity of β-cells in obesity and in other causes of fatty acid spillover. Diabetes. 2001;50(suppl 1): S118-S121.
25. Kelly IE, Han TS, Walsh K, Lean MEJ. Effects of a thiazolidine-dione compound on body fat and fat distribution of patients with type 2 diabetes. Diabetes Care. 1999;22:288-293.
26. Mori Y, Murakawa Y, Okada K, et al. Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diabetes Care. 1999;22:908-912.
27. Akazawa S, Sun F, Ito M, et al. Efficacy of troglitazone on body fat distribution in tvpe 2 diabetes. Diabetes Care. 2000;23:1067-1071.
28. Montague CT, O'Raliillv S. The perils of portliness: causes and consequences of visceral adiposity Diabetes. 2000;49:883-888.
29. Wever C, Folev, JE, Bogardus C, et al. Enlarged subcutaneous abdominal adipocvte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia. 2000;43:1498-1506.
30. Smith PJ, Wise LS, Berkowitz R, et al. Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem. 1988;263:9402-9408.
31. Chaika OV, Chaika N, Voile DJ, et al. CSF-1 receptor/insulin receptor chimera permits CSF-1-dependent differentiation of 3T3-L1 preadipocytes. J Biol Chem. 1997;272:11968-11974.
32. Gagnon A, Sorisky A. The effect of glucose concentration on insulin-induced 3T3-L1 adipose cell differentiation. Obes Res. 1998;6:157-163.
33. Fruman DA, Meyers RE, Cantley LC. Phosphoinositide kinases. Annu Rev Biochem. 1998;67:481-507.
34. Virkamäki A, Held K, Kalin CR. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest. 1999;103:931-943.
35. Tomivama K, Nakata H, Sasa H, et al. Worhnannin, a specific phosphatidylinositol 3-kinase inhibitor, inhibits adipocytic differentiation of 3T3-L1 cells. Biochem Biophys Res Commun. 1995;212:263-269.
36. Hehara T, Tokumitsu Y, Nomura Y. Wortmannin inhibits insulin-induced Ras and mitogen-activated protein kinase activation related to adipocvte differentiation in 3T3-L1 fibroblasts. Biochem Biophys Res Commun. 1995;210:574-580.
37. Magun R, Burgering BM, Coffer PJ, et al. Expression of a constitutively activated form of protein kinase B (c-Akt) in 3T3-L1 preadipose cells causes spontaneous differentiation. Endocrinology 1996;137:3590-3593.
38. Sakaue H, Ogawa W, Matsumoto M, et al. Posttranscriptional control of adipocyte differentiation through activation of phosphoinositide 3-kimase J Biol Chem. 1998;273:28945-28952.
39. Kolin AD, Summers SA, Birnbaum MJ, Roth RA. Expression of a constitutively active Akt ser/thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation J Biol Chem. 1996;271:31372-31378.
40. Soriskv A, Magun R, Gagnon AM. Adipose cell apoptosis: death in the energy depot. Int J Obes Relat Metab Disord. 2000;24(suppl 4):S3-S7.
41. Magun R, Boone DL, Tsang BK, Sorisky A. The effect of adipocyte differentiation on the capacity of 3T3-L1 cells to undergo apoptosis in response to growth factor deprivation. Int J Obes Relat Metab Disord. 1998;22:567-571.
42. Magun R, Gagnon A, Yaraghi Z, Sorisky A. Expression and regulation of neuronal apoptosis inhibitory protein during adipocyte differentiation. Diabetes. 1998;47:1948-1952.
43. Staiger H, Loffler G. The role of PDGF-dependent suppression of apoptosis in differentiating 3T3-L1 preadipocytes. Eur J Cell Biol. 1998;77:220-227.
44. LIrso B, Niesler CH, O'Ralilly S, Siddle K. Comparison of anti-apoptotic signalling by the insulin receptor and IGF-I receptor in preadipocvtes and adipocytes. Cell Signal. 2001;13:279-285.
45. Niesler CU, Ursø B, Prins JB, Siddle K. IGF-I inhibits apoptosis induced by serum withdrawal, but potentiates TNFα-induced apoptosis, in 3T3-L1 preadipocytes. J Endocrinol. 2000;167:165-174.
46. Gagnon A, Dods P, Roustan-Delatour N, et al. Phosphatidy linositol-3,4,5-trisphosphate is required for insulin-like growth factor 1-mediated survival of 3T3-L1 preadipocytes. Endocrinology. 2001;142:205-212.
47. Flexner C. HIV-protease inhibitors. N Engl J Med. 1998;338:1281-1292.
48. Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet. 2000;356:1423-1430.
49. Mulligan K, Grunfeld C, Tai VW, et al. Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection. J Acquir Immune Defic Syndr. 2000;23:35-43.
50. Gagnon A, Angel JB, Soriskv A. Protease inhibitors and adipocyte differentiation in cell culture. Lancet. 1998;352:1032.
51. Nguven AT, Gagnon A, Angel JB, Soriskv A. Ritonavir increases the level of active ADD-1/SREBP-1 protein during adipogenesis. AIDS. 2000;14:2467-2473.
52. Soukas A, Cohen P, Socci ND, Friedman JM. Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev. 2000;14:963-980.
53. Andre P, Groettrup M, Klenerman P, et al. An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses. Proc Natl Acad Sci USA. 1998;95:13120-13124.
54. Wang X, Sato R, Brown MS, et al. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell. 1994;77:53-62.
55. Riddle TM, Kuhel DG, Woollett LA, et al. HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus. J Biol Chem. 2001;276:37514-37519.
56. 1 acid signaling by the HIV protease inhibitor indinavir. Biochem Pharmacol. 2000;59:1063-1068.
57. Dowell P, Flexner C, Kwiterovich PO, Lane MD. Suppression of preadipocvte differentiation and promotion of adipocyte death by HIV protease inhibitors. J Biol Chem. 2000;275:41325-41332.
58. Caron M, Auclair M, Vigouroux C, et al. The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocvte differentiation, and induces insulin resistance. Diabetes. 2001;50:1378-1388.
59. Wentworth JM, Burris TP, Chatterjee VKK. HIV protease inhibitors block human preadipocvte differentiation, but not via die PPARy/RXRheterodimer. J Endocrinol. 2000;164:R7-R10.
60. Zhang B, MacNaul K, Szalkowski D, et al. Inhibition of adipocyte differentiation bv HIV protease inhibitors. J Clin Endocrinol Metab. 1999;84:4274-4277.
61. Domingo P, Marias-Guiu X, Pujol RM, et al. Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy. AIDS. 1999;13:2261-2267.
62. Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev. 2000;21:168-199.
63. Wiersinga WM, Prummel MF. Pathogenesis of Graves' ophthalmopathy-current understanding [editorial]. J Clin Endocrinol Metab. 2001;86:501-503.
64. Cao HJ, Wang HS, Zhang Y, et al. Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase-2 expression. Insights into potential pathogenic mechanisms of thyroid-associated ophthalmopathy. J Biol Chem. 1998;273:29615-29625.
65. Hogg MG, Evans CH, Smith TJ. Leukoregulin induces plasminogen activator inhibitor type 1 in human orbital fibroblasts. Am J Physiol. 1995;269:C359-C366.
66. Yamada M, Li AW, Wall JR. Thyroid-associated ophthalmopathy: clinical features, pathogenesis, and management. Crit Rev Clin Lab Sci. 2000;37:523-549.
67. Soriskv A, Pardasani D, Gagnon A, Smith TJ. Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture. J Clin Endocrinol Metab. 1996;81:3428-3431.
68. Smith TJ, Koumas L, Gagnon A, et al. Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab. 2002;87:385-392.
69. Levton L, Schneider P, Labra CV, et al. Thy-1 binds to integrin p3 on astrocytes and triggers formation of focal contact sites. Curr Biol. 2001;11:1028-1038.
70. Smith TJ, Sempowski GD, Wang HS, et al. Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts. J Clin Endocrinol Metab. 1995;80:2620-2625.
71. Balm RS, Dutton CM, Natt N, et al. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy. J Clin Endocrinol Metab. 1998;83:998-1002.
72. Crisp M, Starkev KJ, Lane C, et al. Adipogenesis in thyroid eye disease. Invest Ophthalmol Vis Sci. 2000;41:3249-3255.
73. Bell A, Gagnon A, Grander L, et al. Functional TSH receptor in human abdominal preadipocvtes and orbital fibroblasts. Am J Physiol Cell Physiol. 2000;279:C335-C340.
74. Valyasevi RW, Erickson DZ, Harteneck DA, et al. Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. J Clin Endocrinol Metab. 1999;84:2557-2562.